Log in to save to my catalogue

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development...

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2822902724

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice

About this item

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Heterozygous mutation targeting proline 95 in Serine/Arginine-rich Splicing Factor 2 (SRSF2) is associated with V617F mutation in Janus Activated Kinase 2 (JAK2) in some myeloproliferative neoplasms (MPNs), most commonly primary myelofibrosis. To explore the interaction of
Srsf2
P95H
with
Jak2
V617F
, we generated Cre-inducible kn...

Alternative Titles

Full title

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2822902724

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2822902724

Other Identifiers

ISSN

0887-6924,1476-5551

E-ISSN

1476-5551

DOI

10.1038/s41375-023-01878-0

How to access this item